Morton F Goldberg

ANECORTAVE ACETATE AS MONOTHERAPY FOR THE TREATMENT OF SUBFOVEAL LESIONS IN PATIENTS WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION (AMD): Interim (Month 6) Analysis of Clinical Safety and Efficacy

J. Slakter, S. Russell, L. Yannuzzi, 2003, Retina.

Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration: twelve-month clinical outcomes.

J. Slakter, S. Russell, L. Yannuzzi, 2003, Ophthalmology.